FindTrial
Sign In

Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review

Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review - Research trends on the use of Asenapine for Delirium in Patients with Cancer: A scoping review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000058326
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium,Cancer

Interventions

None listed

Sponsors

Shiroishi Tomo Mental Clinic,Department of Psychiatry,ISHIDA Tetsuro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Research on the use of asenapine for delirium in cancer patients.

Exclusion criteria

Exclusion criteria: 1.Duplicated publications 2.Conference proceedings 3.Reviews which are not based on systematic review 4.Study protocols 5.Other psychiatric diagnosis (e.g., Schizophrenia, Bipolar disorder) 6.Other neurological diagnosis (e.g., Epilepsy, Parkinson's disease) 7.Articles written in languages other than English or Japanese

Design outcomes

Primary

MeasureTime frame
The use of asenapine for patients with cancer and delirium—

Countries

Japan

Contacts

Public ContactTetsuro ISHIDA

Shiroishi Tomo Mental Clinic Department of Psychiatry

teturoisida@yahoo.co.jp011-598-1439

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026